JNJ-42396302

DB12657InvestigationalSmall molecule

Jnj 42396302 is under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Participants).

Formula / weight: C₁₉H₂₃N₅O₂ · 353.426 g/mol (avg)
Code names: JNJ-42396302

Resolves to

Compound

UNIIP5M4972608CAS1298030-18-8ChEMBLCHEMBL2180408PubChem51352628

Structure

InChIKeyBPLVDYJDAVYLRQ-UHFFFAOYSA-NSMILESCOCCC1=CC=C(C=N1)C1=C(C)N=C2N1N=CC=C2N1CCOCC1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of JNJ-42396302, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account